These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12856057)

  • 21. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.
    Correia ML; Haynes WG
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):643-60. PubMed ID: 16083333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
    Preuss HG; DiFerdinando D; Bagchi M; Bagchi D
    J Med; 2002; 33(1-4):247-64. PubMed ID: 12939122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-obesity drug use before professional treatment in Taiwan.
    Liou TH; Wu CH; Chien HC; Lin WY; Lee WJ; Chou P
    Asia Pac J Clin Nutr; 2007; 16(3):580-6. PubMed ID: 17704041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fighting fat. New drugs against obesity in the pipeline.
    Brower V
    EMBO Rep; 2002 Jul; 3(7):601-3. PubMed ID: 12101089
    [No Abstract]   [Full Text] [Related]  

  • 25. Taranabant, a novel cannabinoid type 1 receptor inverse agonist.
    Fremming BA; Boyd ST
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1116-29. PubMed ID: 18821475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the pharmacological treatment of obesity.
    Schnee DM; Zaiken K; McCloskey WW
    Curr Med Res Opin; 2006 Aug; 22(8):1463-74. PubMed ID: 16870072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Slim339 in reducing body weight of overweight and obese human subjects.
    Toromanyan E; Aslanyan G; Amroyan E; Gabrielyan E; Panossian A
    Phytother Res; 2007 Dec; 21(12):1177-81. PubMed ID: 17639559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use and costs of bariatric surgery and prescription weight-loss medications.
    Encinosa WE; Bernard DM; Steiner CA; Chen CC
    Health Aff (Millwood); 2005; 24(4):1039-46. PubMed ID: 16012144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Obesity and health economics. Review and status].
    Pedersen KM; Worre-Jensen AL
    Ugeskr Laeger; 2006 Jan; 168(2):196-201. PubMed ID: 16403351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug treatment of obesity.
    Bray GA
    Psychiatr Clin North Am; 2005 Mar; 28(1):193-217, ix-x. PubMed ID: 15733619
    [No Abstract]   [Full Text] [Related]  

  • 31. Challenges in the discovery and development of new agents for the treatment of obesity.
    Staten MA
    Clin Pharmacol Ther; 2007 May; 81(5):753-5. PubMed ID: 17377527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medications as adjunct therapy for weight loss: approved and off-label agents in use.
    Moyers SB
    J Am Diet Assoc; 2005 Jun; 105(6):948-59. PubMed ID: 15942547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk-sharing agreements for innovative drugs: a new solution to old problems?
    de Pouvourville G
    Eur J Health Econ; 2006 Sep; 7(3):155-7. PubMed ID: 16912890
    [No Abstract]   [Full Text] [Related]  

  • 34. The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development.
    Opgenorth TJ
    Curr Opin Investig Drugs; 2008 Apr; 9(4):355-6. PubMed ID: 18393101
    [No Abstract]   [Full Text] [Related]  

  • 35. [Xenical--a modern perspective drug for the treatment of obesity (review)].
    Mkrtumian AM; Biriukova EV
    Ter Arkh; 2007; 79(10):35-9. PubMed ID: 18154143
    [No Abstract]   [Full Text] [Related]  

  • 36. Deal watch: Bristol-Myers Squibb and Exelixis collaborate on kinase inhibitors.
    Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180098
    [No Abstract]   [Full Text] [Related]  

  • 37. Another type of intervention: treating obesity with medication.
    Greenway F
    J Am Diet Assoc; 2005 Jun; 105(6):895-8. PubMed ID: 15942538
    [No Abstract]   [Full Text] [Related]  

  • 38. Red mold rice prevents the development of obesity, dyslipidemia and hyperinsulinemia induced by high-fat diet.
    Chen WP; Ho BY; Lee CL; Lee CH; Pan TM
    Int J Obes (Lond); 2008 Nov; 32(11):1694-704. PubMed ID: 18794894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Social ills.
    Bloice C; Hallinan CM
    Revolution (Oakl); 2005; 6(2):18-25. PubMed ID: 15948533
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmaceutical companies join forces on HIV.
    Butler D
    Nature; 2009 Apr; 458(7241):950-1. PubMed ID: 19396104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.